UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Discover effective ways to generate income without spending any money. These tips will help you build your finances effortlessly.
23,664 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This in depth review breaks down the lien 2026 earnings transcript in plain language. You’ll see what the numbers mea...
Oracle reports a surge in cloud revenue and record backlog, but shares drift. Market talk centers on whether AI infra...
Seniors often find that switching medicare advantage easy is simple, but returning to Original Medicare with Medigap ...
A domestic sting underscores how easily scams prey on seniors. Explore how the scheme worked, the red flags to watch ...
Lucid shares rebound for a second day after the CEO refutes bankruptcy and take-private rumors, with investors eyeing...
Axon Enterprise jumped in premarket trading following a strong Q4 and a sharp rise in annual bookings, signaling dura...
Tensions around the Strait of Hormuz threaten a key energy route that could ripple through markets and household budg...
Oil prices have spiked more than 25% since the conflict began, but oil stocks have barely moved. This guide explains ...
A small exodus of California's billionaires ahead of a proposed wealth tax could erase billions in expected revenue. ...
Netflix and Meta are trading lower from recent highs, but their risk profiles differ. This piece weighs which merit a...
Stocks edge higher as Nvidia earnings loom, lifting the S&P 500 and Nasdaq. This stock market live 2026 update tracks...